Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Arbe Robotics Ltd. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0.33
2.25
3.52
1.47
0.77
1.03
Cost of revenue
0.34
1.44
1.28
1.51
1.55
1.83
Gross profit
-0.01
0.81
2.23
-0.04
-0.79
-0.8
Research and development
22
12.8
28.6
36.7
34.1
35.1
34.8
Selling and marketing
1.93
1.06
1.81
4.62
5.19
5.43
5.04
General and administrative
1.19
1.09
3.71
8.61
7.57
8.35
7.54
Operating expenses
25.1
15
34.1
50
46.8
48.9
47.4
Operating income
25.1
-15
-33.3
-47.7
-46.9
-49.7
-48.2
Other non-operating income
0.48
0.67
-24.8
7.24
3.39
0.34
1.78
Pre-tax income
25.6
15.6
58.1
40.5
43.5
49.3
46.4
Net income
-25.6
-15.6
-58.1
-40.5
-43.5
-49.3
-46.4
EBITDA
25.4
-14.7
-32.9
-47.3
-46.3
-49.1
-47.7
EPS, basic
-1.40
-2.18
-0.64
-0.60
-0.61
-0.42
EPS, diluted
-1.40
-2.18
-0.66
-0.61
-0.61
-0.42
Shares, basic (weighted)
11.2
26.7
63.5
72
80.9
111
Shares, diluted (weighted)
11.2
26.7
63.6
72.1
80.9
111
Balance sheet
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
7
2.86
101
54.2
28.6
13.5
4.03
Short-term investments
0.1
0.4
15.4
10.8
40.7
Receivables
0.14
0.19
2.2
1.26
0.15
0.57
Other current assets
0.83
3.06
1.84
2.03
30.4
24.5
Total current assets
4.02
104
58.8
47.4
57.6
71.8
Property, plant and equipment
0.38
1.17
1.61
1.31
1.37
1.18
Lease right-of-use assets
0.47
1.74
1.78
0.89
Total assets
4.41
105
60.8
50.5
60.8
73.8
Accounts payable
1.21
2.01
1.24
1.15
0.62
0.77
Accrued liabilities
1.54
3.1
2.86
2.92
3.28
3.71
Deferred revenue
0.28
0.73
0.35
Short-term debt
1.88
4.92
0.02
Total current liabilities
5.27
15.5
10.4
6.21
36.4
32.9
Long-term debt
0.68
Lease liabilities
0.02
1.31
1.46
1.35
Total liabilities
64.6
25.5
12.1
8.39
38.3
34.3
Total debt
2.56
0.02
Paid-in capital
1.4
199
209
246
275
339
Retained earnings
-61.6
-120
-160
-204
-253
-299
Shareholders' equity
-45.1
-60.2
79.8
48.8
42.1
22.5
39.6
Total equity
-45.1
-60.2
79.8
48.8
42.1
22.5
39.6
Total liabilities and equity
4.41
105
60.8
50.5
60.8
73.8
Shares outstanding
11.2
76.4
64.2
77.9
85.7
109
Cash flow statement
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
25.6
15.6
58.1
-40.5
-43.5
-49.3
-46.4
Depreciation and amortization
0.24
0.23
0.34
0.48
0.56
0.59
0.54
Stock-based compensation
0.41
0.44
2.21
8.79
13
14.5
9.14
Change in receivables
-0.14
-0.05
-2.02
0.69
1.11
Cash from operations
-22.6
-15.3
-26.4
-40.4
-33.5
-32.5
-38.1
Capital expenditures
-0.23
-0.16
-0.78
-0.92
-0.25
-0.62
-0.3
Cash from investing
-8.54
9.7
-0.68
-1.32
-15.3
3.99
-24.7
Debt issued
4.76
Debt repaid
-0.56
-1.59
-2.64
Stock issued
0.03
0.22
0.28
22.5
13.8
30.8
Dividends paid
-525
-525
Cash from financing
35.5
1.53
125
-4.94
23.2
13.5
53.4
Exchange rate effect
1.19
-0.05
-0.26
Net change in cash
4.45
-4.05
98
-45.4
-25.6
-15.2
-9.37
Free cash flow
-22.8
-15.4
-27.2
-41.3
-33.8
-33.1
-38.4
Interest paid
0.26
0.41
0.21
0.25
1.93
0.29
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $0.64 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
-78.2%
Gross profit / revenue.
Operating margin
-4,698.0%
Operating income / revenue.
EBITDA margin
-4,646.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
4,524.0%
Pre-tax income / revenue.
Net margin
-4,524.0%
Net income / revenue.
FCF margin
-3,745.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-3,716.0%
Cash from operations / revenue.
Return on equity (ROE)
-149.6%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-69.0%
Net income / average total assets.
Return on invested capital (ROIC)
-171.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
3,394.0%
Research and development expense / revenue.
Stock-based pay / revenue
891.0%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
29.5%
Capital expenditures / revenue.
D&A / revenue
52.4%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
33.6%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-33.7%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
25.3%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
75.9%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-6.7%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
21.5%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
6.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
75.7%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
37.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
20.5%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
58.4%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.18x
Current assets / current liabilities.
Quick ratio
1.38x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.36x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.42
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.01
Revenue / diluted weighted shares.
FCF per share
-$0.35
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.34
Cash from operations / diluted weighted shares.
Book value per share
$0.36
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
78.9x
Market cap / revenue.
P/B
2.04x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
2.04x
Market cap / tangible book value, when positive.
EV/Sales
35.3x
Enterprise value / revenue.
FCF yield
-47.5%
Free cash flow / market cap.
Earnings yield
-57.4%
Net income / market cap (the inverse of P/E).
What was Arbe Robotics Ltd.'s revenue in fiscal 2025?
Arbe Robotics Ltd. reported revenue of $1.0M for fiscal 2025, 33.6% higher than the year before.
Was Arbe Robotics Ltd. profitable in fiscal 2025?
No. It reported a net loss of $46.4M.
How much free cash flow did Arbe Robotics Ltd. generate in fiscal 2025?
Cash from operations of $38.1M minus capital expenditures of $303.0K left free cash flow of -$38.4M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.